A Cryoablation Devices Market, By Device Type (Systems, and Probes), by Application (Prostate Cancer, Renal Cancer, Liver Cancer, Breast Cancer, and Others), by End User (Hospitals

Cryoablation Devices Market, By Device Type (Systems, and Probes), by Application (Prostate Cancer, Renal Cancer, Liver Cancer, Breast Cancer, and Others), by End User (Hospitals, Ambulatory Surgical Centers, and Surgical Clinics), and by Regions (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Cryotherapy and radiofrequency ablation (RFA) are the two clinically viable ablation systems that are widely used in liver cancer management. Cryotherapy is a treatment that uses extreme cold for denaturing the diseased tissues in the human body. The procedure is often carried out multiple times till the affected tissue is totally destroyed. The technique yields high effectiveness for treatment of various tumors such as that in the bones, kidneys, breasts, lungs, and liver, and can also be used to treat certain skin conditions. The probe is guided using MRI and ultrasound, which locates the exact position of the affected tissue that provides the targeted therapy.
Market Dynamics
Adoption of cryoablation procedures is growing as cryoablation is a minimally invasive procedure that decreases the chances of major surgery and thus helps with rapid recovery of the patient. Percutaneous procedure used for the therapy involves use of a thin, needle size probe that is inserted in the body through a small incision. In 2017, according to Radcliffe Cardiology, cryoablation process for treating cardiac arrhythmia is now being considered as a safe and effective alternative to radio frequency ablation therapy.
Key features of the study:
This report provides in-depth analysis of the global cryoablation devices market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cryoablation devices market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Medtronic Inc., Galil Medical Inc., AtriCure, Inc., IceCure Medical, CryoConcepts LP, Brymill Cryogenic Systems, CooperSurgical, and Sanarus Technologies
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global cryoablation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cryoablation devices market
Detailed Segmentation:
Global Cryoablation Devices Market, By Device Type:
Systems
Probes
Global Cryoablation Devices Market, By Application:
Prostate Cancer
Renal Cancer
Liver Cancer
Breast Cancer
Others
Global Cryoablation Devices Market, By End User:
Hospitals
Ambulatory Surgical Centers
Surgical Clinics
Global Cryoablation Devices Market, By Region:
North America
By Device Type:
Systems
Probes
By Application:
Prostate Cancer
Renal Cancer
Liver Cancer
Breast Cancer
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Surgical Clinics
By Country:
U.S.
Canada
Latin America
By Device Type:
Systems
Probes
By Application:
Prostate Cancer
Renal Cancer
Liver Cancer
Breast Cancer
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Surgical Clinics
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Device Type:
Systems
Probes
By Application:
Prostate Cancer
Renal Cancer
Liver Cancer
Breast Cancer
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Surgical Clinics
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Device Type:
Systems
Probes
By Application:
Prostate Cancer
Renal Cancer
Liver Cancer
Breast Cancer
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Surgical Clinics
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Device Type:
Systems
Probes
By Application:
Prostate Cancer
Renal Cancer
Liver Cancer
Breast Cancer
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Surgical Clinics
By Country:
GCC
Israel
Rest of Middle East
Africa
By Device Type:
Systems
Probes
By Application:
Prostate Cancer
Renal Cancer
Liver Cancer
Breast Cancer
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Surgical Clinics
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Medtronic Inc.*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Galil Medical Inc.
AtriCure, Inc.
IceCure Medical
CryoConcepts LP
Brymill Cryogenic Systems
Cooper Surgical
Sanarus Technologies
“*” marked represents similar segmentation in other categories in the respective section.